Quest Diagnostics has introduced two Post-COVID-19 panels for consumers that offer information about lingering health issues associated with previous COVID-19 virus infections.

Becton Dickinson announced that it received 510(k) clearance from the US Food and Drug Administration for a high-throughput assay to detect vaginitis.

On 13 March, BioMérieux China signed a strategic cooperation agreement with Accunome Biotechnology Co., Ltd.

By the end of 2022, there were 1,033,000 medical and health institutions in China, including 37,000 hospitals. The medical and health institutions in China possessed 9.75 million beds, of which hospitals possessed 7.66 million and township health centers had 1.45 million.